We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$1.25B
AUM Growth
+$41.9M
Cap. Flow
-$10.5M
Cap. Flow %
-0.84%
Top 10 Hldgs %
63.99%
Holding
314
New
23
Increased
136
Reduced
120
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 6.74%
2 Financials 4%
3 Healthcare 3.52%
4 Consumer Staples 2.49%
5 Consumer Discretionary 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAF icon
301
GrafTech
EAF
$199M
$157K 0.01%
1,282
+90
+8% +$10.4K
ING icon
302
ING
ING
$102B
$146K 0.01%
11,967
-8,939
-43% -$95K
CS
303
DELISTED
Credit Suisse Group
CS
$111K 0.01%
10,508
-4,187
-28% -$56.7K
BBVA icon
304
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
$71K 0.01%
+13,545
New +$71.4K
GNW icon
305
Genworth Financial
GNW
$3.77B
$36K ﹤0.01%
10,906
-6,998
-39% -$23K
AWK icon
306
American Water Works
AWK
$27B
-2,165
Closed -$332K
EQIX icon
307
Equinix
EQIX
$105B
-351
Closed -$251K
GE icon
308
GE Aerospace
GE
$380B
-2,172
Closed -$117K
GWW icon
309
W.W. Grainger
GWW
$61.7B
-598
Closed -$244K
IEMG icon
310
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
-5,049
Closed -$313K
LUMN icon
311
Lumen
LUMN
$6.53B
-29,547
Closed -$288K
MCK icon
312
McKesson
MCK
$104B
-1,168
Closed -$203K
ROL icon
313
Rollins
ROL
$17.6B
-5,795
Closed -$226K
VRTX icon
314
Vertex Pharmaceuticals
VRTX
$134B
-984
Closed -$233K

Similar funds

Balasa Dinverno & Foltz's Q1 2021 Portfolio in Review

As of Q1 2021, Balasa Dinverno & Foltz held 314 positions worth $1.25B, up 3.5% from $1.21B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Balasa Dinverno & Foltz's Q1 2021 filing shows 23 new, 136 increased, 120 reduced and 9 closed positions. Its largest new stake was Alexion Pharmaceuticals: 1,959 shares worth $300K. The largest sale was Vanguard Morningstar Small-Cap Growth ETF, an estimated $9.2M.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.6% a quarter earlier, followed by Financials and Healthcare.

  • Balasa Dinverno & Foltz's largest Q1 2021 buy was Alexion Pharmaceuticals: 1,959 shares worth $300K.
  • Balasa Dinverno & Foltz added most to Vanguard Morningstar Growth ETF in Q1 2021, an estimated $2.98M increase.
  • Balasa Dinverno & Foltz's biggest Q1 2021 reduction was Vanguard Morningstar Small-Cap Growth ETF, cutting an estimated $9.2M.
  • Balasa Dinverno & Foltz fully exited American Water Works in Q1 2021, selling an estimated $332K.
  • Balasa Dinverno & Foltz's ten largest holdings make up 64% of its $1.25B portfolio in Q1 2021.
  • Balasa Dinverno & Foltz opened 23 new positions and closed 9 in Q1 2021.
  • Balasa Dinverno & Foltz's portfolio value rose 3.5% quarter-over-quarter to $1.25B.

Based on Balasa Dinverno & Foltz's 13F filing for Q1 2021, filed 29 Apr 2021.